Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubatio
Phase 2
- Conditions
- Respiratory Distress Syndrome.Respiratory distress syndrome
- Registration Number
- IRCT201411183915N12
- Lead Sponsor
- Research Vice Chancellor for Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
gestation age 33-37 weeks; confirmed diagnosis of respiratory distress syndrome according to clinical and radiological findings; treatment with surfactant
Exclusion criteria: major congenital anomalies; congenital heart disease; cranio-facial anomalies; esophageal atresia; birth weight less than 1800 grams
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced needed FiO2 to maintain adequate oxygenation. Timepoint: Before and one hour after surfactant therapy. Method of measurement: Determination of needed Fio2 in blender and by pulse oxymetry.
- Secondary Outcome Measures
Name Time Method eed for intubation and assisted ventilation. Timepoint: Till 3 days after treatment. Method of measurement: Pulse oxymetry and blood gas analysis.